Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction
Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
Published on: October 20, 2023
Matthias Fischer1, Thomas Raabe2
1Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
Abstract:
Loss of function mutations in the rsk2 gene cause Coffin-Lowry syndrome (CLS), which is associated with multiple symptoms including severe mental disabilities. Despite the characterization of ribosomal S6 kinase 2 (RSK2) as a protein kinase acting as a downstream effector of the well characterized ERK MAP-kinase signaling pathway, it turns out to be a challenging task to link RSK2 to specific neuronal processes dysregulated in case of mutation. Animal models such as mouse and Drosophila combine advanced genetic manipulation tools with in vivo imaging techniques, high-resolution connectome analysis and a variety of behavioral assays, thereby allowing for an in-depth analysis for gene functions in the nervous system. Although modeling mental disability in animal systems has limitations because of the complexity of phenotypes, the influence of genetic variation and species-specific characteristics at the neural circuit and behavioral level, some common aspects of RSK2 function in the nervous system have emerged, which will be presented. Only with this knowledge our understanding of the pathophysiology of CLS can be improved, which might open the door for development of potential intervention strategies.
Insights
Loss of function mutations in the ribosomal S6 kinase 2 (RSK2) gene cause Coffin-Lowry syndrome (CLS). Animal models reveal common aspects of RSK2 function in the nervous system, aiding CLS pathophysiology understanding.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Coffin-Lowry syndrome (CLS) is caused by loss-of-function mutations in the ribosomal S6 kinase 2 (RSK2) gene, leading to severe mental disabilities.
- RSK2 is a protein kinase in the ERK MAP-kinase signaling pathway, but its specific neuronal functions in CLS pathophysiology are not well understood.
Purpose of the Study:
- To investigate the role of RSK2 in nervous system function using animal models.
- To identify common aspects of RSK2 function relevant to CLS.
Main Methods:
- Utilized mouse and Drosophila models for genetic manipulation and in vivo imaging.
- Employed high-resolution connectome analysis and behavioral assays to study RSK2 function.
- Acknowledged limitations in modeling mental disability due to phenotypic complexity and species-specific differences.
Main Results:
- Identified common functional aspects of RSK2 in the nervous system across different animal models.
- Established a foundation for understanding RSK2's role in neural circuits and behavior.
Conclusions:
- Understanding RSK2's nervous system functions is crucial for improving CLS pathophysiology knowledge.
- This research may pave the way for developing novel intervention strategies for CLS.
Related Concept Videos
Bronsted-Lowry Acids and Bases
What is a Nervous System?
Brønsted-Lowry Acids and Bases
The Parasympathetic Nervous System
The Sympathetic Nervous System
Water: A Bronsted-Lowry Acid and Base

